U.S. markets closed
  • S&P 500

    3,911.74
    +116.01 (+3.06%)
     
  • Dow 30

    31,500.68
    +823.32 (+2.68%)
     
  • Nasdaq

    11,607.62
    +375.43 (+3.34%)
     
  • Russell 2000

    1,765.74
    +54.06 (+3.16%)
     
  • Crude Oil

    107.06
    +2.79 (+2.68%)
     
  • Gold

    1,828.10
    -1.70 (-0.09%)
     
  • Silver

    21.13
    +0.09 (+0.42%)
     
  • EUR/USD

    1.0559
    +0.0034 (+0.33%)
     
  • 10-Yr Bond

    3.1250
    +0.0570 (+1.86%)
     
  • GBP/USD

    1.2274
    +0.0013 (+0.11%)
     
  • USD/JPY

    135.1600
    +0.2270 (+0.17%)
     
  • BTC-USD

    21,165.93
    +224.80 (+1.07%)
     
  • CMC Crypto 200

    462.12
    +8.22 (+1.81%)
     
  • FTSE 100

    7,208.81
    +188.36 (+2.68%)
     
  • Nikkei 225

    26,491.97
    +320.72 (+1.23%)
     

Johnson & Johnson Joins the Breakup Club: Here's How to Play It

·4 min read
Johnson & Johnson Joins the Breakup Club: Here's How to Play It
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Just days after industrial conglomerate General Electric announced that firm's future de-conglomerization, and less recently after fellow pharmaceutical giants Pfizer and Merck had spun out their respective consumer businesses, comes the next shoe to drop. Johnson & Johnson , the world's largest health products company by sales and employer of more than 136K human beings, announced that the longstanding member of the Dow Jones Industrial Average will be separating into two distinct firms, but not right away. A push to simplify business direction in order to improve focus during complex times?